Incyte
Active
VC
Deal flow
$40M
1 round
Unicorns
0
≥ $1B valuation
Founded
—
Latest
May 2026
Genesis Therapeutics
Venture capital firm tracking 1 AI investment, with focus on Drug Discovery. Total tracked deal flow: $40M.